Fed. Circ. Nixes Injunction On Lupin's Generic Fortamet

The Federal Circuit on Monday lifted an injunction barring Lupin Ltd. from selling its generic version of Shionogi Pharma Inc.'s diabetes drug Fortamet, ruling that questions remain over whether the patent...

Already a subscriber? Click here to view full article